癌症流行病學論文

  1. Ou YJ, Chiu HF, Wong YH, Yang CC, Yang YH: Bisphosphonate use and the risk of breast cancer: a meta-analysis of observational studies. Pharmacoepidemiol Drug Saf 2017, 26(10):1286-1295.
  2. Huang WW, Hsieh KP, Huang RY, Yang YH: Role of cyclooxygenase-2 inhibitors in the survival outcome of colorectal cancer patients: A population-based cohort study. Kaohsiung J Med Sci 2017, 33(6):308-314.
  3. Doss JG, Ghani WMN, Razak IA, Yang YH, Rogers SN, Zain RB: Changes in health-related quality of life of oral cancer patients treated with curative intent: experience of a developing country. Int J Oral Maxillofac Surg 2017, 46(6):687-698.
  4. Chiang W-F, Yang Y-H: The impact of comorbidities on the management and prognosis of oropharyngeal and hypopharyngeal cancer patients in Taiwan. Translational Research in Oral Oncology 2017, 2:2057178X1772543.
  5. Chiang SL, Velmurugan BK, Chung CM, Lin SH, Wang ZH, Hua CH, Tsai MH, Kuo TM, Yeh KT, Chang PY et al: Preventive effect of celecoxib use against cancer progression and occurrence of oral squamous cell carcinoma. Sci Rep 2017, 7(1):6235.
  6. Yang Y-H, Warnakulasuriya S: Effect of comorbidities on the management and prognosis in patients with oral cancer. Translational Research in Oral Oncology 2016, 1:2057178X1666996.
  7. Tsai MJ, Wu PH, Sheu CC, Hsu YL, Chang WA, Hung JY, Yang CJ, Yang YH, Kuo PL, Huang MS: Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients. Sci Rep 2016, 6:23979.
  8. Ou YJ, Chiu HF, Wong YH, Yang YH: Bisphosphonate use and the risk of endometrial cancer: a meta-analysis of observational studies. Pharmacoepidemiol Drug Saf 2016, 25(10):1107-1115.
  9. Huang RY, Hsieh KP, Huang WW, Yang YH: Use of lithium and cancer risk in patients with bipolar disorder: population-based cohort study. Br J Psychiatry 2016, 209(5):393-399.
  10. Hsieh KP, Chen LC, Cheung KL, Yang YH: Risks of nonadherence to hormone therapy in Asian women with breast cancer. Kaohsiung J Med Sci 2015, 31(6):328-334.
  11. Hsieh KP, Chen LC, Cheung KL, Yang YH: A competing risk analysis of hormone therapy interruption in Asian women with breast cancer. Pharmacoepidemiol Drug Saf 2015, 24(3):301-309.
  12. Cho SF, Yang YH, Liu YC, Hsiao HH, Huang CT, Wu CH, Tsai YF, Wang HC, Liu TC: Previous Exposure to Statin May Reduce the Risk of Subsequent Non-Hodgkin Lymphoma: A Nationwide Population-Based Case-Control Study. PLoS One 2015, 10(10):e0139289.
  13. Cho SF, Wu WH, Yang YH, Liu YC, Hsiao HH, Chang CS: Longitudinal risk of herpes zoster in patients with non-Hodgkin lymphoma receiving chemotherapy: A nationwide population-based study. Sci Rep 2015, 5:14008.
  14. Cho SF, Wu WH, Yang YH, Chang CS: Risk of second primary cancer in patients with B-cell non-Hodgkin lymphoma receiving rituximab-containing chemotherapy: a nationwide population-based study. Anticancer Res 2015, 35(3):1809-1814.
  15. Lee MY, Hsiao PJ, Yang YH, Lin KD, Shin SJ: The association of pioglitazone and urinary tract disease in type 2 diabetic Taiwanese: bladder cancer and chronic kidney disease. PLoS One 2014, 9(1):e85479.
  16. Hsieh KP, Chen LC, Cheung KL, Chang CS, Yang YH: Interruption and non-adherence to long-term adjuvant hormone therapy is associated with adverse survival outcome of breast cancer women–an Asian population-based study. PLoS One 2014, 9(2):e87027.
  17. Chang LT, Chen CH, Yang YH, Ho PS: The development and validation of oral cancer staging using administrative health data. BMC Cancer 2014, 14:380.
  18. Shen L, Shan YS, Hu HM, Price TJ, Sirohi B, Yeh KH, Yang YH, Sano T, Yang HK, Zhang X et al: Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol 2013, 14(12):e535-547.
  19. Yang YH, Yang YH, Cheng CL, Ho PS, Ko YC: The role of chemoprevention by selective cyclooxygenase-2 inhibitors in colorectal cancer patients – a population-based study. BMC Cancer 2012, 12:582.
  20. Liu YC, Yang YH, Hsiao HH, Yang WC, Liu TC, Chang CS, Yang MY, Lin PM, Hsu JF, Chang PY et al: Herpes zoster is associated with an increased risk of subsequent lymphoid malignancies – a nationwide population-based matched-control study in Taiwan. BMC Cancer 2012, 12:503.
  21. Lan CC, Ko YC, Yu HS, Li WC, Wu CS, Lu YW, Yang YH, Chen GS: Psoriatic patients with diabetes are prone to develop digestive organ cancers: a population-based study in Taiwan. J Dermatol Sci 2012, 68(2):82-88.
  22. Chang CS, Yang YH, Hsu CN, Lin MT: Trends in the treatment changes and medication persistence of chronic myeloid leukemia in Taiwan from 1997 to 2007: a longitudinal population database analysis. BMC Health Serv Res 2012, 12:359.
  23. Chang CS, Lee K, Yang YH, Lin MT, Hsu CN: Estimation of CML incidence: disagreement between national cancer registry and health claims data system in Taiwan. Leuk Res 2011, 35(5):e53-54.
  24. Yang YH, Liu SH, Ho PS, Huang IY, Chen CH, Shieh TY: Conditional survival rates of buccal and tongue cancer patients: how far does the benefit go? Oral Oncol 2009, 45(2):177-183.
  25. Ho PS, Yang YH, Shieh TY, Huang IY, Chen YK, Lin KN, Chen CH: Consumption of areca quid, cigarettes, and alcohol related to the comorbidity of oral submucous fibrosis and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007, 104(5):647-652.
  26. Ho PS, Yang YH, Shieh TY, Chen CH, Tsai CC, Ko YC: Ethnic differences in the occurrence of oropharyngeal cancer in Taiwan. Public Health 2007, 121(10):765-773.
  27. Chen PH, Shieh TY, Ho PS, Tsai CC, Yang YH, Lin YC, Ko MS, Tsai PC, Chiang SL, Tu HP et al: Prognostic factors associated with the survival of oral and pharyngeal carcinoma in Taiwan. BMC Cancer 2007, 7:101.
  28. Ariyawardana A, Sitheeque MA, Ranasinghe AW, Perera I, Tilakaratne WM, Amaratunga EA, Yang YH, Warnakulasuriya S: Prevalence of oral cancer and pre-cancer and associated risk factors among tea estate workers in the central Sri Lanka. J Oral Pathol Med 2007, 36(10):581-587.
  29. Chung FM, Yang YH, Chen CH, Lin CC, Shieh TY: Angiotensin-converting enzyme gene insertion/deletion polymorphism is associated with risk of oral precancerous lesion in betel quid chewers. British Journal of Cancer 2005, 93(5):602-606.
  30. Chung CH, Yang YH, Wang TY, Shieh TY, Warnakulasuriya S: Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in southern Taiwan. J Oral Pathol Med 2005, 34(8):460-466.
  31. Lin CL, Lieu AS, Lee KS, Yang YH, Kuo TH, Hung MH, Loh JK, Yen CP, Chang CZ, Howng SL et al: The conditional probabilities of survival in patients with anaplastic astrocytoma or glioblastoma multiforme. Surg Neurol 2003, 60(5):402-406; discussion 406.
  32. Ho PS, Ko YC, Yang YH, Shieh TY, Tsai CC: The incidence of oropharyngeal cancer in Taiwan: an endemic betel quid chewing area. J Oral Pathol Med 2002, 31(4):213-219.
  33. Hwang SL, Yang YH, Lieu AS, Chuang MC, Chang SJ, Chang YY, Lin HJ, Howng SL: The conditional survival statistics for survivors with primary supratentorial astrocytic tumors. J Neurooncol 2000, 50(3):257-264.